| Literature DB >> 34477931 |
A Pal1,2, J Schneider3,4, F Rosenberger3, P Zimmer5, K Schlüter3,4, K Steindorf1, J Wiskemann3.
Abstract
PURPOSE: Induction of IDO depends on the activation of AhR forming the AhR/IDO axis. Activated AhR can transcribe various target genes including cytotoxic and inhibiting receptors of NK cells. We investigated whether AhR and IDO levels as well as activating (NKG2D) and inhibiting (KIR2DL1) NK cell receptors are influenced by acute exercise and different chronic endurance exercise programs.Entities:
Keywords: Cancer; Exercise; IDO/TDO; Kynurenine; NK Cell; Physical activity; Tryptophan
Mesh:
Substances:
Year: 2021 PMID: 34477931 PMCID: PMC8571223 DOI: 10.1007/s00421-021-04735-z
Source DB: PubMed Journal: Eur J Appl Physiol ISSN: 1439-6319 Impact factor: 3.078
Fig. 1Major metabolites of the Tryptophan metabolism pathway in humans. IDO indoleamine 2,3-dioxygenase; TDO Tryptophan 2,3-dioxygenase; KAT KYN aminotrasferase I; KMO KYN monooxygenase; 3-HK 3-hudroxyKynurenine; KYNU Kynureninase (Pal et al. 2021)
Anthropometric and clinical parameters of patient population
| Study | Endurance polarized | Endurance standard |
|---|---|---|
| TOTAL ( | 12 | 9 |
| Age (years), mean (SD) | 60.67 (8.70) | 59.11 (9.87) |
| BMI (kg/m2), mean (SD) | 26.14 (3.53) | 28.53 (4.01) |
| VO2peak (ml/min/kg), mean (SD) | 23.03 (3.68) | 21.6 (4.71) |
| Breast cancer, | 7 (58.33) | 4 (44.44) |
| Prostate cancer, | 5 (41.66) | 5 (55.55) |
| Stage, | ||
| I | 9 (75) | 7 (77.77) |
| II | 3 (25) | 2 (22.22) |
| III | 0 (0) | 0 (0) |
| IV | 0 (0) | 0 (0) |
| Treatment, | ||
| Adjuvant hormone therapy | 7 (58.33) | 5 (55.55) |
| Antibody therapy | 1 (8.3) | 1 (11.11) |
| Neo-adjuvant chemotherapy | 0 (0) | 2 (22.22) |
| Intraoperative radiation therapy | 1 (8.3) | 0 (0) |
| Radiation therapy | 9 (75) | 6 (66.66) |
| Operative procedures, | 10 (83.33) | 8 (88.88) |
n number of participants, SD standard deviation, BMI body mass index, VO peak oxygen uptake
Fig. 2Acute effects of a single bout of endurance exercise: mean expression of AhR, IDO and NK cell receptors KIR2DL1 and NKG2D are plotted at pre-CPET, post-CPET and 1 h post- CPET. Data are presented as means with 95% confidence intervals. A AhR B IDO C KIR2DL1, D NKG2D (data listed in Supplementary Table 1). X-axis: time, Y-axis: % positive cells. *indicating results of statistical significance
Fig. 3Chronic effects of different modalities of endurance exercise: baseline adjusted mean expression of AhR, IDO and NK cell receptors are plotted at pre-CPET and after 12 weeks of chronic exercise training modalities. Data are presented as means with 95% confidence intervals (endurance polarized: blue n = 12, endurance standard: dashed red n = 9). A AhR, B IDO, C KIR2DL1, D NKG2D (data listed in Supplementary Table 2). X-axis: time, Y-axis: % positive cells. *indicating results of statistical significance